Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC): Final analysis of the TREE-StudyH. S. Hochster, Barrett H. Childs, Eric Hedrick et al.|Journal of Clinical Oncology|2006Cited by 137